{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:14:38Z","timestamp":1778519678761,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005771","name":"Dokuz Eyl\u00fcl \u00dcniversitesi","doi-asserted-by":"publisher","award":["KB.SAG.052"],"award-info":[{"award-number":["KB.SAG.052"]}],"id":[{"id":"10.13039\/501100005771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.urolonc.2020.02.021","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T02:04:52Z","timestamp":1584410692000},"page":"476-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of cancer stem cells in immunotherapy for bladder cancer: An in vitro study"],"prefix":"10.1016","volume":"38","author":[{"given":"Yegane","family":"\u00d6zcan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulya","family":"\u00c7a\u011flar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe Banu","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe P\u0131nar","family":"Er\u00e7etin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zekiye","family":"Altun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safiye","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.02.021_bib0001","series-title":"Muscle-invasive and metastatic bladder cancer","author":"Witjes","year":"2018"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/528690","article-title":"Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer","volume":"2012","author":"Zhu","year":"2012","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/232609","article-title":"Predictive biomarkers of bacillus Calmette-Gu\u00e9rin immunotherapy response in bladder cancer: where are we now?","volume":"2012","author":"Lima","year":"2012","journal-title":"Adv Urol"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0004","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5858\/arpa.2011-0471-RA","article-title":"Emerging critical role of molecular testing in diagnostic genitourinary pathology","volume":"136","author":"Netto","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/528353","article-title":"Pathobiology and chemoprevention of bladder cancer","volume":"2011","author":"Tanaka","year":"2011","journal-title":"J Oncol"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0006","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1756287211431976","article-title":"Best practice in the treatment of nonmuscle invasive bladder cancer","volume":"4","author":"Anastasiadis","year":"2012","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0007","series-title":"EAU guidelines on non-muscle-invasive bladder cancer","author":"Babjuk","year":"2018"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0008","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2217\/pme.11.15","article-title":"Genetic susceptibility to bladder cancer risk and outcome","volume":"8","author":"Gu","year":"2011","journal-title":"Per Med"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0009","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s11095-008-9566-7","article-title":"Intravesical treatments of bladder cancer: review","volume":"25","author":"Shen","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2249.2010.04105.x","article-title":"Interleukin-10 inhibits mycobacterium bovis bacillus Calmette\u2013Gu\u00e9rin (BCG)-induced macrophage cytotoxicity against bladder cancer cells","volume":"160","author":"Luo","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0011","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/728930","article-title":"Th1 cytokine-secreting recombinant mycobacterium bovis bacillus Calmette-Gu\u00e9rin and prospective use in immunotherapy of bladder cancer","volume":"2011","author":"Luo","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0012","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2217\/1750743X.1.2.281","article-title":"Bacillus Calmette\u2013Guerin immunotherapy for urothelial carcinoma of the bladder","volume":"1","author":"Kresowik","year":"2009","journal-title":"Immunotherapy"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0013","doi-asserted-by":"crossref","first-page":"14016","DOI":"10.1073\/pnas.0906549106","article-title":"Identification. molecular characterization. clinical prognosis and therapeutic targeting of human bladder tumor initiating cells","volume":"106","author":"Chan","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0014","doi-asserted-by":"crossref","first-page":"e40267","DOI":"10.1371\/journal.pone.0040267","article-title":"Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20 and IL-28A","volume":"9","author":"Lee","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.1211623","article-title":"Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-\u03b1 but not through TRAIL and FasL","volume":"92","author":"Jinesh","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0016","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.urolonc.2007.11.031","article-title":"Role of neutrophils in BCG immunotherapy for bladder cancer","volume":"26","author":"Simons","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0017","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2567.2007.02792.x","article-title":"Expression of chemokine\/cytokine genes and immune cell recruitment following the instillation of mycobacterium bovis, bacillus Calmette-Gu\u00e9rin or lactobacillus rhamnosus strain GG in the healthy murine bladder","volume":"124","author":"Seow","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0018","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1097\/01.ju.0000091826.83705.79","article-title":"Cytokine gene expression in a mouse model: the first instillations with viable bacillus Calmette-Guerin determine the succeeding Th1 response","volume":"170","author":"De Boer","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/181987","article-title":"Bladder cancer immunotherapy: BCG and beyond","volume":"2012","author":"Askeland","year":"2012","journal-title":"Adv Urol"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0020","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1245\/s10434-018-6706-0","article-title":"Predictive value of CD44 in muscle-invasive bladder cancer and its relationship with IL-6 signaling","volume":"25","author":"Wu","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0021","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1101\/gad.1549407","article-title":"Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis","volume":"21","author":"Ancrile","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0022","doi-asserted-by":"crossref","first-page":"25277","DOI":"10.1016\/S0021-9258(18)47243-2","article-title":"Cloning and characterization of the human neutrophil-activating peptide (ENA-78)","volume":"269","author":"Chang","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0023","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/geno.1996.4594","article-title":"The human MCP-2 gene (SCYA8): cloning, sequence analysis, tissue expression, and assignment to the CC chemokine gene contig on chromosome 17q11.2","volume":"40","author":"Van Coillie","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0024","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/78765","article-title":"CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex","volume":"3","author":"Elson","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0025","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1073\/pnas.82.18.6250","article-title":"Cloning, sequence, and expression of a human granulocyte\/macrophage colony-stimulating factor","volume":"82","author":"Cantrell","year":"1985","journal-title":"Proc Nat Acad Sci"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0026","doi-asserted-by":"crossref","first-page":"10418","DOI":"10.1021\/bi026020q","article-title":"The CXCR3 binding chemokine IP-10\/CXCL10: structure and receptor interactions","volume":"41","author":"Booth","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.urolonc.2020.02.021_bib0027","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbrc.2015.06.175","article-title":"XCR1 promotes cell growth and migration and is correlated with bone metastasis in non-small cell lung cancer","volume":"464","author":"Wang","year":"2015","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920300624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920300624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:06:04Z","timestamp":1778519164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920300624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1078143920300624"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.02.021","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of cancer stem cells in immunotherapy for bladder cancer: An in vitro study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}